Hermetica Superfood Encyclopedia
The Short Answer
Cocona fruit contains carotenoids (all-trans-lutein, all-trans-β-carotene), phenolics, flavonoids, and spermidine alkaloids that contribute to antioxidant radical scavenging and lipid-lowering activity via modulation of lipid metabolism. Preclinical data from animal studies demonstrated a mean 41.52% statistically significant reduction (p < 0.05) in serum total cholesterol and triglycerides, though no human clinical trials have yet confirmed these effects.
CategoryFruit
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordcocona fruit benefits
Cocona — botanical close-up
Health Benefits
**Antioxidant Activity**
Hydroethanolic extracts scavenge DPPH and ABTS free radicals (IC50 606.3 ± 3.5 μg/mL and 290.3 ± 10.7 μg/mL respectively), with activity attributed to phenolic compounds, flavonoids, and carotenoids donating electrons or hydrogen atoms to neutralize reactive oxygen species.
**Antihyperlipidemic Potential**
Preclinical evidence indicates cocona extracts produce a statistically significant mean 41.52% reduction in serum total cholesterol and triglycerides (p < 0.05), suggesting modulation of lipid biosynthesis or transport pathways, though exact molecular targets remain uncharacterized.
**Carotenoid Delivery**
The fruit is a meaningful dietary source of all-trans-lutein (24–44% of carotenoid fraction) and all-trans-β-carotene (24–30%), supporting macular health and serving as a provitamin A source, particularly relevant in Amazonian populations with limited access to diverse carotenoid-rich foods.
**Niacin and Potassium Contribution**
Per 100 g fresh fruit, cocona provides approximately 2.3–2.5 mg niacin (14.1% NRC) and 385.4 mg potassium (19.3% NRC), contributing meaningfully to NAD⁺ precursor status and electrolyte balance in traditional dietary contexts.
**Vitamin C Supply**: Ascorbic acid content ranges from 4
5 to 13.9 mg per 100 g (up to 15.3% NRC depending on ecotype), supporting collagen synthesis and immune function, with ecotype and ripeness stage being primary determinants of concentration.
**Digestive Acidity and Organic Acid Profile**
The fruit's organic acid content, including citric acid (~0.8%) and quinic acid, contributes to an acidic pH (Brix/acidity ratio 5.9) historically associated with mild digestive stimulation and traditional use for gastrointestinal complaints in Peruvian Amazonian communities.
**Polyamine (Spermidine) Content**
Metabolomic profiling identified two spermidine derivatives within cocona's 30-compound metabolome; spermidines are bioactive polyamines linked to autophagy induction and cellular longevity pathways in broader nutritional research, though direct evidence in S. sessiliflorum remains preliminary.
Origin & History
Natural habitat
Solanum sessiliflorum, commonly called cocona or cubiu, is native to the upper Amazon basin, with primary cultivation across Peru, Brazil, and Colombia at elevations between 200–1,000 meters in humid tropical forest margins. The plant thrives in well-drained, fertile loamy soils with high rainfall and consistent warm temperatures, and is commonly grown in home gardens and small-scale agroforestry plots by indigenous Amazonian communities. Multiple distinct ecotypes exist across the region, contributing to measurable variation in fruit size, phytochemical content, and nutritional profile across studies.
“Solanum sessiliflorum has been cultivated and consumed by indigenous Amazonian peoples in present-day Peru, Brazil, and Colombia for centuries, valued primarily as a food crop rather than a formal medicinal plant, though traditional healers have employed it for mild digestive complaints attributed to its acidic profile. In Peruvian Amazonia, the fruit is known locally as 'cocona' and occupies a culturally significant role in regional cuisine, appearing in chicha (fermented beverages), hot sauces, and fresh preparations that form part of everyday dietary patterns. Brazilian Amazonian communities, particularly in the state of Amazonas, refer to the fruit as 'cubiu' and have historically selected distinct ecotypes for size, flavor, and yield through informal domestication over generations. No formal historical pharmacopeial listing or colonial-era botanical record specifically designating S. sessiliflorum as a medicinal substance has been identified, distinguishing it from more formally documented Amazonian medicinal species, and its traditional therapeutic use remains anecdotal and orally transmitted.”Traditional Medicine
Scientific Research
The scientific evidence base for Solanum sessiliflorum is limited to a small number of phytochemical characterization studies, metabolomic analyses, in vitro antioxidant assays, and at least one preclinical (animal model) antihyperlipidemic study, with no peer-reviewed human clinical trials identified in available literature. In vitro antioxidant studies report DPPH IC50 of 606.3 ± 3.5 μg/mL and ABTS IC50 of 290.3 ± 10.7 μg/mL for hydroethanolic extracts, demonstrating activity markedly weaker than ascorbic acid (IC50 2.74 ± 0.3 μg/mL), contextualizing the fruit as a moderate dietary antioxidant source rather than a potent therapeutic agent. Metabolomic work identified 30 distinct compounds including glycosylated flavonols, quinic acid, raffinose, isocitric acid, and two spermidine derivatives, providing a basis for mechanistic hypotheses but not confirming clinical efficacy. The antihyperlipidemic animal data showing 41.52% cholesterol/triglyceride reduction (p < 0.05) is promising but requires validation in controlled human trials with defined dosing, duration, and population characteristics before any clinical recommendations can be made.
Preparation & Dosage
Traditional preparation
**Fresh Fruit (Traditional)**
89–93 g; eaten raw, juiced, or incorporated into sauces and fermented beverages in Amazonian households; no therapeutic dose established
Consumed whole at typical unit weights of .
**Juice/Aqueous Extract**
Prepared by pressing fresh pulp; used in traditional contexts for digestive complaints; no standardized concentration or therapeutic dose defined in literature.
**Hydroethanolic Extract (Research Grade)**
4 mg per 100 g fresh weight equivalent; no commercial standardized supplement form currently available
70% ethanol/water extraction used in phytochemical and antioxidant studies; phenolic content approximately 14..
**Dietary Supplement Potential**
Pulp, peel, and seeds all contain distinct mineral and phytochemical profiles; peel and seeds may concentrate carotenoids and phenolics; whole-fruit powders or standardized carotenoid extracts represent logical future forms but are not commercially established.
**Standardization Note**
No established standardization percentages for phenolics, carotenoids, or alkaloids exist for commercial preparations; ecotype and processing method significantly affect phytochemical yield.
**Timing**
No pharmacokinetic data available to guide timing recommendations; traditional consumption is mealtime-integrated as a food.
Nutritional Profile
Per 100 g fresh fruit: energy 31–45 kcal, protein 0.6–0.9 g, lipids 1.4–1.9 g, dietary fiber 0.2–0.9 g, total sugars 4.6%, reducing sugars 1.0–3.9 g. Micronutrients include ascorbic acid 4.5–13.9 mg, niacin 2.3–2.5 mg, potassium 385.4 mg, and notably high sodium at 371 mg per 100 g (74.2% NRC), which is atypically elevated for a fresh fruit and warrants attention in sodium-restricted populations. Carotenoid fraction is dominated by all-trans-lutein (24–44%), all-trans-β-carotene (24–30%), all-trans-neoxanthin (4–19%), 9-cis-neoxanthin (4–9%), and 9-cis-violaxanthin; total phenolics approximately 14.4 mg per 100 g. Metabolomic profiling identified glycosylated flavonols, flavanols, spermidine derivatives, quinic acid, isocitric acid, protocatechuic acid glycoside, and raffinose. Bioavailability of carotenoids is expected to be enhanced by the fruit's intrinsic lipid content (1.4–1.9 g per 100 g), consistent with known fat-soluble carotenoid absorption physiology, though species-specific bioaccessibility studies have not been conducted.
How It Works
Mechanism of Action
The primary antioxidant mechanism of Solanum sessiliflorum extracts involves electron and hydrogen atom transfer from phenolic hydroxyl groups and carotenoid conjugated double-bond systems to DPPH and ABTS radical species, with flavonols and protocatechuic acid 5-O-apiofuranosyl-glucose (m/z 461.13023) identified as probable lead contributors in metabolomic profiling. Antihyperlipidemic activity, observed as statistically significant reductions in serum cholesterol and triglycerides in preclinical models, likely involves interference with hepatic lipid biosynthesis or enhanced lipoprotein catabolism, though specific enzyme targets such as HMG-CoA reductase or lipoprotein lipase have not been confirmed for this species. Spermidine derivatives detected in the fruit metabolome may contribute to autophagy pathway activation via mTORC1 inhibition, consistent with spermidine's established mechanism in other botanical sources, but this has not been experimentally validated in S. sessiliflorum. Alkaloids confirmed via Dragendorff and Bertrand reagents may exert additional bioactivity, though their precise identity, targets, and contribution to observed effects remain uncharacterized at the receptor or gene-expression level.
Clinical Evidence
No human clinical trials for Solanum sessiliflorum have been identified in the peer-reviewed literature, representing a significant evidence gap. The most quantitatively meaningful preclinical finding is a statistically significant mean 41.52% reduction in serum total cholesterol and triglycerides (p < 0.05) observed in an animal lipid model, though the specific animal species, sample size, dose, duration, and extract standardization of this study were not fully specified in available sources. In vitro studies consistently demonstrate radical scavenging capacity via DPPH and ABTS assays across multiple ecotypes, but IC50 values are substantially higher than pharmaceutical antioxidants, limiting direct therapeutic extrapolation. Overall confidence in clinical efficacy for any specific health indication remains very low, and all reported benefits should currently be considered hypothesis-generating rather than evidence-based.
Safety & Interactions
Solanum sessiliflorum has a long history of safe traditional food use across Amazonian communities with no documented reports of acute toxicity, allergic reactions, or adverse events in the ethnographic or scientific literature; however, formal toxicology studies, including subchronic and chronic toxicity assessments, are entirely absent. As a member of the Solanaceae family, the potential presence of steroidal alkaloids (confirmed variably via Dragendorff and Bertrand reagent testing) warrants precautionary awareness, particularly with high-dose extracts, although solanine-specific quantification for this species is not available in published literature. The fruit's high sodium content (approximately 371 mg per 100 g, representing 74.2% of NRC) represents a meaningful dietary concern for individuals on sodium-restricted diets, including those managing hypertension, heart failure, or chronic kidney disease. No specific drug interactions have been documented, and no contraindications for pregnancy or lactation have been established, though the absence of safety data in these populations means caution is warranted until dedicated studies are conducted.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Solanum sessiliflorum DunalCubiuCoconaTopiroOrinoco apple
Frequently Asked Questions
What are the main health benefits of cocona fruit?
Cocona provides dietary carotenoids (all-trans-lutein 24–44% and all-trans-β-carotene 24–30% of the carotenoid fraction), phenolics, and flavonoids that confer antioxidant activity and, in preclinical animal studies, a statistically significant mean 41.52% reduction in serum cholesterol and triglycerides (p < 0.05). It also contributes meaningful amounts of niacin (2.3–2.5 mg per 100 g, ~14% NRC) and potassium (385.4 mg per 100 g, ~19% NRC) to the diet. However, no human clinical trials have confirmed these benefits, so cocona is best considered a nutritious food rather than a clinically validated therapeutic agent.
Is there scientific evidence supporting cocona for cholesterol reduction?
The available evidence is limited to preclinical animal data showing a mean 41.52% reduction in serum total cholesterol and triglycerides (p < 0.05), with no human clinical trials published as of current literature. The exact animal model, dosing regimen, duration, and extract type used in this study were not fully specified in accessible sources, limiting the strength of conclusions. Until randomized controlled trials in humans are conducted with standardized cocona preparations, its cholesterol-lowering effect cannot be recommended as a clinical intervention.
What compounds in cocona are responsible for its antioxidant activity?
Cocona's antioxidant activity is primarily attributed to its phenolic compounds, flavonoids (including glycosylated flavonols and flavanols), carotenoids (lutein, β-carotene, neoxanthin), and organic acids such as protocatechuic acid 5-O-apiofuranosyl-glucose. Hydroethanolic extracts demonstrate DPPH radical scavenging at an IC50 of 606.3 ± 3.5 μg/mL and ABTS scavenging at 290.3 ± 10.7 μg/mL, indicating moderate in vitro antioxidant capacity. These values are substantially weaker than ascorbic acid (IC50 2.74 ± 0.3 μg/mL), positioning cocona as a dietary antioxidant food source rather than a concentrated therapeutic antioxidant.
Is cocona safe to eat, and are there any side effects or drug interactions?
Cocona has a long history of safe traditional consumption as a food in Amazonian communities, with no documented adverse events in ethnographic or scientific records. Formal toxicology studies are absent, and as a Solanaceae family member, variable presence of steroidal alkaloids in extracts warrants caution with concentrated supplement preparations. Its notably high sodium content (~371 mg per 100 g, approximately 74% of NRC) may be a concern for individuals on sodium-restricted diets, and no drug interaction data are currently available.
How is cocona traditionally prepared and consumed in the Amazon?
In Peruvian and Brazilian Amazonian communities, cocona is eaten fresh at typical unit sizes of 89–93 g, pressed into juices, incorporated into hot sauces, or fermented into traditional beverages (chicha). The fruit's acidic profile (approximately 0.8% citric acid, Brix/acidity ratio 5.9) has led to traditional use for mild digestive complaints. No standardized supplement form, commercial extract, or established therapeutic dosage currently exists; all documented uses reflect whole-food dietary integration rather than concentrated supplementation.
What is the bioavailability of cocona's antioxidant compounds, and does processing affect their absorption?
Cocona's phenolic compounds, flavonoids, and carotenoids are present in bioavailable forms, though extraction methods significantly influence their concentration and absorption potential. Hydroethanolic extraction demonstrates superior free radical scavenging efficiency compared to water-based preparations, suggesting that solvent choice during processing or supplementation formulation may enhance the bioavailability of its active phytochemicals. Fresh fruit consumption provides the full matrix of compounds, while concentrated extracts may offer higher doses of specific antioxidants but may not retain all synergistic co-factors present in whole fruit.
How does cocona compare to other Amazonian fruits in terms of antioxidant potency and bioactive profile?
Cocona demonstrates notable antioxidant capacity with IC50 values of 606.3 μg/mL (DPPH) and 290.3 μg/mL (ABTS), positioning it within a competitive range for rainforest superfruits, though direct comparative studies with acai, cupuaçu, or guarana are limited. What distinguishes cocona is its specific phenolic and carotenoid profile, which may provide unique antihyperlipidemic and cholesterol-modulating effects beyond general antioxidant activity. Its traditional use alongside its emerging preclinical evidence suggests it offers complementary rather than superior benefits compared to better-studied Amazonian alternatives.
What populations or health conditions would benefit most from cocona supplementation based on current research?
Individuals with elevated lipid profiles or those at risk for metabolic dysfunction may benefit most from cocona, given preclinical evidence for antihyperlipidemic activity, though human clinical trials remain limited. Those seeking broad-spectrum antioxidant support from whole-food sources rather than isolated compounds may also find cocona supplementation valuable, particularly if conventional fruit intake is restricted. However, more targeted research in specific populations (hypertensive patients, diabetics, or those on statin therapy) is needed to establish clear candidate demographics for therapeutic use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cocona-solanum-sessiliflorum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
